REWARDS Premier Taxus-Liberte vs Xience V

MedStar Health

Status: Completed

Conditions: Coronary Artery Disease

Treatments: Other: Observational

Study type: Observational

Funder types: Other

Identifiers

NCT02256527

REWARDS Premier TLX

Details and patient eligibility

About

Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in which patients received either the Taxus Liberte or XIENCE V drug eluting stent.

Enrollment: 917 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients 18 years of age or older
• Underwent PCI with Promus Premier (alone) DES

Exclusion criteria

• Underwent PCI with a non-Promus Premier DES during the same index procedure
• Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel, prasugrel, or ticagrelor)

Trial design

917 participants in 1 patient group

Promus Premier

Description:

observational data

Treatment:

Other: Observational